University of Southern California (USC)

COVID-19, influenza and suicide fuel increase in deaths among ICE detainees

Better infection control and psychiatric care needed

Newswise — Thirty-five people have died in the custody of U.S. Immigration and Customs Enforcement (ICE) since April 2018, with a seven-fold increase in deaths even as the average daily population decreased by nearly a third between 2019 and 2020, a new USC study shows.

"Potentially preventable causes of death -- including COVID-19 infection, influenza and suicide -- are responsible for at least half of recent deaths," said researcher Sophie Terp, an assistant professor of clinical emergency medicine at the Keck School of Medicine of USC and a clinical scholar at the USC Schaeffer Center for Health Policy and Economics.

For the study, the USC researchers examined three years of congressionally mandated reports on deaths in ICE custody. Their findings appear in the journal AIMS Public Health.

The death rate -- 10.833 per 100,000 detainees -- is the highest since ICE implemented their Performance-Based National Detention Standards in 2008, researchers said. The findings lend support to civil liberties organizations' longstanding concerns that substandard medical care in ICE facilities has contributed to preventable deaths.

Overall, nine people died by suicide and 26 people died from medical causes. Eight of the medical deaths were attributed to COVID-19, which represents 72.7% of 11 deaths occurring since April 2020.

The paper also includes two case studies describing circumstances surrounding recent deaths in ICE custody.

In one case, a 54-year-old citizen of Mexico fell ill one month after being taken into custody two decades after first entering the United States. A nurse noted that the patient appeared normal "except a heart rate of 103 and pulse oximetry reading of 83%." A normal blood oxygen level is typically between 95 and 100%. Interventions such as supplementary oxygen or hospitalization were not recorded. The man died the following day.

In another case, a 55-year-old Russian citizen detained after nearly 20 years in the United States was put on suicide watch after he said: "If I can't go home, then I just want to kill myself." Over the next year, the man was diagnosed with acute stress disorder, anxiety, insomnia and hallucinations. The report indicates that although the man had low blood pressure, care providers continued to prescribe him a medication that controls high blood pressure until they ended the treatment. He was eventually hospitalized for small bowel obstruction and anemia and placed on suicide watch. He left the hospital against medical advice and died the following day.

"Refusing to cooperate with care for a diagnosed bowel obstruction while on suicide watch [raises] questions about the detained individual's capacity to refuse care for a potentially life-threatening condition and whether mental health issues may have been contributory to this death," the researchers wrote.

The researchers noted that most of the COVID-19-related deaths occurred among detained individuals whose age or medical conditions -- including diabetes, chronic kidney disease or lymphoma -- put them at high risk for severe illness and for death from COVID-19.

"Safety measures such as masks, hand hygiene and social distancing can be difficult to implement in often-crowded detention environments," Terp said. "Although the COVID vaccine was not yet available during the study period, immunization should be prioritized for incarcerated populations."

The fact that most of the people who died were detained for more than a month before they died suggests conditions in detention, rather than events prior to detention, contributed to premature death, the researchers said. In addition, the average age at death -- 47.3 years -- is markedly lower than the reported life expectancy for foreign-born individuals in the United States.

"This is concerning, particularly considering that foreign-born individuals in the United States have a 2.4-year advantage in life-expectancy relative to United States-born population," Terp and her colleagues wrote. "There is considerable room for the improvement of infection control measures, as well as access to and quality of psychiatric care and suicide prevention efforts for individuals in ICE detention."

###

In addition to Terp, other authors of the study include Sameer Ahmed, Briah Fischer, Madeline Ross, Molly Grassini, Elizabeth Burner and Parveen Parmary, all of the Keck School of Medicine.

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 6109
Newswise: Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Released: 2-Aug-2021 4:25 PM EDT
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Hackensack Meridian Health

New COVID-19 40-day mortality risk model, published in The Public Library of Science ONE, has potential for use in patient treatment planning, comparisons of therapeutic strategies, and public-health preparations.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 2:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Newswise: COVID-19: Small Sign of Hope as Vaccinations Rise
Released: 2-Aug-2021 10:45 AM EDT
COVID-19: Small Sign of Hope as Vaccinations Rise
Cedars-Sinai

As COVID-19 cases spike in Los Angeles and throughout the Golden State, driven by the spread of the delta variant among unvaccinated residents, there may be a small sign of hope: More people are finally getting their shot.

Newswise: New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
Released: 31-Jul-2021 10:05 AM EDT
New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
University of Miami Health System, Miller School of Medicine

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.

Released: 30-Jul-2021 2:05 PM EDT
Thinking Impaired in 60% of COVID-19 Survivors, Study Finds
University of Texas Health Science Center at San Antonio

In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the Alzheimer’s Association International Conference.

Released: 30-Jul-2021 11:50 AM EDT
Support for Government Mandates High and Increasing Over Time, Survey Finds
Rutgers University-New Brunswick

As the coronavirus Delta variant surges throughout the country and mask and vaccine mandates are being considered, a new national survey finds that almost 20 percent of Americans say it is unlikely that they will get the COVID-19 vaccine.


Showing results

110 of 6109

close
1.53698